Table 5.
Pathological Condition | Cell Therapy | Estimated Enrollment | Intervention/ Treatment |
Cliniclatrials.Gov Identifier | Outcome Measures |
---|---|---|---|---|---|
Women infertility with thin endometrium or endometrial scarring. | UCMSCs loaded in collagen scaffold | 50 participants | UCMSC-based therapy | NCT03592849 | Evaluation of endometrial thickness, pregnancy rate, living intrauterine fetus, live birth rate, endometrial blood flow, menstrual blood volume and adversities such as infection, allergies, abdominal pain post-operation. |
Women with POI | AECs | 20 participants | Minimally invasive implantation AECs used with ultrasound guidance | NCT03207412 | Evaluation of serum FSH, primordial egg follicles number, menstrual cycle and menstrual period, LH, AMH and E2, ovarian volume. |
Repeated IVF failure women with atrophic endometrium | Autologous BMSCs | 46 participants | Transplantation of BMSCs | NCT03166189 | Evaluation of endometrial receptivity, endometrial thickness, pregnancy rate, adversities such as side effects, abdominal discomfort and patient’s tolerance. |
Women with POF | Autologous BMSCs | 33 participants | Transplantation of BMSCs | NCT02696889 | Evaluation of FSH, AMH, E2 level, menstruation resumption, pregnancy achievement. |
Women with POF | Autologous AMSCs | 9 participants | Intra-ovarian injection of AMSCs | NCT02603744 | Evaluation of FSH, AMH, antral follicle number and volume, menstruation recurrence rate and pregnancy rate. |
Women infertility with intrauterine adhesions | UCMSCs loaded in collagen scaffold | 26 participants | UCMSC-based therapy | NCT02313415 | Evaluation of live birth rate, intrauterine adhesion reduction, change of endometrial thickness, menstrual blood volume. |
Women infertility with intrauterine adhesions and endometrial dysplasia | Autologous BMSCs loaded in collagen scaffold | 30 participants | BMSC-based therapy | NCT02204358 | Evaluation of intrauterine scar reduction, endometrial thickness, menstrual blood volume and pregnancy rate. |
Women with POF | Autologous BMSCs | 60 participants | Transplantation of BMSCs | NCT02062931 | Evaluation of FSH, AMH, E2 level, hormonal, clinical, ultra sound, menopausal symptoms and pregnancy rate. |
UCMSCs: umbilical cord mesenchymal stem cells; AECs: amniotic epithelial cells; BMSCs: bone marrow-derived mesenchymal stem cells; AMSCs: adipose mesenchymal stem cells; POF: pre-mature ovarian failure; POI: pre-mature ovarian insufficiency; FSH: follicular stimulating hormone; LH: luteinizing hormone; AMH: anti Mullerian hormone; and E2: estradiol.